This invention encompasses a pharmaceutical composition comprising a pharmaceutical carrier and an effective lipoxygenase inhibiting amount of a compound of the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are the same or different members of the group consisting of 1,1-dimethylethyl, halo, phenyl and substituted phenyl; Alk is straight or branched chain lower alkylene; R.sub.4 is hydrogen or lower alkyl; R.sub.3 is hydrogen or lower alkyl. The formulation of this invention are useful as anti-inflammatory and anti-allergy agents.
本发明涵盖了一种药物组合物,包括药物载体和公式为:##STR1##的化合物的有效抑制脂氧合酶量,其中:R.sub.1和R.sub.2是
1,1-二甲基乙基,卤素,苯基和取代苯基组成的群体中相同或不同的成员;Alk是直链或支链低级烷基;R.sub.4是氢或低级烷基;R.sub.3是氢或低级烷基。本发明的配方可用作抗炎和抗过敏剂。